The MarketWatch News Department was not involved in the creation of this content. ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis ...
BRANFORD, Conn., Oct. 20, 2025 /PRNewswire/ -- Azitra, Inc. (AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results